We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
426
Charles River Laboratories
CRL
$12.7B
$616K 0.01%
+3,053
New +$692K
H icon
427
PUT
Hyatt Hotels
H
$16.8B
$600K 0.01%
+215,500
New +$23.6M
INBX
428
DELISTED
Inhibrx, Inc. Common Stock
INBX
$600K 0.01%
+31,800
New +$740K
EDR
429
DELISTED
Endeavor Group Holdings, Inc.
EDR
$598K 0.01%
+25,000
New +$557K
RAIN
430
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$593K 0.01%
+67,842
New +$627K
SLN
431
Silence Therapeutics
SLN
$569M
$591K 0.01%
+95,383
New +$1.12M
SPY icon
432
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$586K 0.01%
+395,000
New +$158M
ESTC icon
433
Elastic
ESTC
$7.68B
$579K 0.01%
+10,000
New +$570K
CNTB
434
Connect Biopharma Holdings
CNTB
$138M
$574K 0.01%
+574,148
New +$626K
DBTX
435
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$572K 0.01%
+189,386
New +$655K
PTON icon
436
PUT
Peloton Interactive
PTON
$2.49B
$567K 0.01%
+485,000
New +$5.83M
PROK icon
437
ProKidney
PROK
$345M
$564K 0.01%
+49,782
New +$530K
RIG icon
438
PUT
Transocean
RIG
$5.7B
$558K 0.01%
+485,000
New +$3.11M
CRNX icon
439
Crinetics Pharmaceuticals
CRNX
$8.91B
$537K 0.01%
+33,421
New +$619K
RIVN icon
440
Rivian
RIVN
$22.8B
$526K 0.01%
+34,000
New +$574K
GPCR icon
441
Structure Therapeutics
GPCR
$3.72B
$525K 0.01%
+22,050
New +$518K
LCA
442
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$521K 0.01%
+51,785
New +$519K
RIOT icon
443
Riot Platforms
RIOT
$7.8B
$519K 0.01%
+52,000
New +$338K
PTC icon
444
PTC
PTC
$16.2B
$513K 0.01%
+4,000
New +$509K
CCL icon
445
Carnival Corporation Ltd
CCL
$38.9B
$500K 0.01%
+49,250
New +$510K
TRIP icon
446
TripAdvisor
TRIP
$1.29B
$497K 0.01%
+25,000
New +$534K
RETA
447
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$477K 0.01%
+5,250
New +$308K
SDGR icon
448
Schrodinger
SDGR
$1.33B
$476K 0.01%
+18,081
New +$430K
EDIT icon
449
Editas Medicine
EDIT
$455M
$464K 0.01%
+64,050
New +$569K
INTU icon
450
Intuit
INTU
$91.4B
$446K 0.01%
+1,000
New +$411K

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.